Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Ann B Millar"'
Autor:
David O Bates, Athina Mavrou, Yan Qiu, James G Carter, Maryam Hamdollah-Zadeh, Shaney Barratt, Melissa V Gammons, Ann B Millar, Andrew H J Salmon, Sebastian Oltean, Steven J Harper
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68399 (2013)
Vascular Endothelial Growth Factor-A (VEGF-A) can be generated as multiple isoforms by alternative splicing. Two families of isoforms have been described in humans, pro-angiogenic isoforms typified by VEGF-A165a, and anti-angiogenic isoforms typified
Externí odkaz:
https://doaj.org/article/c5e11b23554f49f3992873cd602d0d0f
Autor:
Beatriz Guillen-Guio, Megan L. Paynton, Richard J. Allen, Daniel P.W. Chin, Lauren J. Donoghue, Amy Stockwell, Olivia C. Leavy, Tamara Hernandez-Beeftink, Carl Reynolds, Paul Cullinan, Fernando Martinez, Helen L. Booth, William A. Fahy, Ian P. Hall, Simon P. Hart, Mike R. Hill, Nik Hirani, Richard B. Hubbard, Robin J. McAnulty, Ann B. Millar, Vidya Navaratnam, Eunice Oballa, Helen Parfrey, Gauri Saini, Ian Sayers, Martin D. Tobin, Moira K.B. Whyte, Ayodeji Adegunsoye, Naftali Kaminski, Shwu-Fan Ma, Mary E. Strek, Yingze Zhang, Tasha E. Fingerlin, Maria Molina-Molina, Margaret Neighbors, X. Rebecca Sheng, Justin M. Oldham, Toby M. Maher, Philip L. Molyneaux, Carlos Flores, Imre Noth, David A. Schwartz, Brian L. Yaspan, R. Gisli Jenkins, Louise V. Wain, Edward J. Hollox
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the pathogenesis of IPF, and a prior ass
Externí odkaz:
https://doaj.org/article/473a7531d84a4f018fe7880dc13a5162
Autor:
Shaney L. Barratt, Thomas Blythe, Khadija Ourradi, Caroline Jarrett, Gavin I. Welsh, David O. Bates, Ann B. Millar
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-5 (2018)
Abstract Dysregulation of VEGF-A bioavailability has been implicated in the development of lung injury/fibrosis, exemplified by Idiopathic Pulmonary Fibrosis (IPF). VEGF-A is a target of the hypoxic response via its translational regulation by HIF-1
Externí odkaz:
https://doaj.org/article/120bb84e425d477797fb1bb9fb2175c7
Publikováno v:
ERJ Open Research, Vol 3, Iss 1 (2017)
Idiopathic pulmonary fibrosis (IPF) has an unpredictable course and prognostic factors are incompletely understood. We aimed to identify prognostic factors, including multidimensional indices from a significant IPF cohort at the Bristol Interstitial
Externí odkaz:
https://doaj.org/article/24a94cc0d3d34f31ae6fc3e5f3271ccc
Autor:
Simon P. Hart, Vilmundur Gudnason, Yingze Zhang, Hiroto Hatabu, Rebecca Braybrooke, R. Gisli Jenkins, Shwu-Fan Ma, Michael Ng, Carlos Flores, George T. O'Connor, Ma'en Obeidat, Nik Hirani, Brian D. Hobbs, Megan L. Paynton, Amy Dressen, Ayodeji Adegunsoye, Helen Booth, Dominic Furniss, Philippe Joubert, Eunice Oballa, Ian Sayers, Martin D. Tobin, Krina T. Zondervan, Richard Hubbard, Xuan Li, Yohan Bossé, John D. Newell, Beatriz Guillen-Guio, Ann B. Millar, Wim Timens, Mary E. Strek, Gunnar Gudmundsson, Philip L. Molyneaux, Gary M. Hunninghake, Ani Manichaikul, Tasha E. Fingerlin, Rachel K. Putman, Richard J. Allen, Vidyia Navaratnam, Maria Molina-Molina, Don D. Sin, Helen Parfrey, Luke M. Kraven, Moira K. B. Whyte, Xuting R. Sheng, Phuwanat Sakornsakolpat, David J. Lederer, David C. Nickle, Ian P. Hall, Brian L. Yaspan, Louise V. Wain, Toby M. Maher, Gauri Saini, Ke Hao, Michael Hill, Naftali Kaminski, Andrew P. Morris, Hanfei Xu, Justin M. Oldham, David A. Schwartz, Robin J. McAnulty, Michael H. Cho, Victor E. Ortega, Margaret Neighbors, Imre Noth, William A. Fahy
Publikováno v:
Allen, R J, Guillen-guio, B, Oldham, J M, Ma, S, Dressen, A, Paynton, M L, Kraven, L M, Obeidat, M, Li, X, Ng, M, Braybrooke, R, Molina-molina, M, Hobbs, B D, Putman, R K, Sakornsakolpat, P, Booth, H L, Fahy, W A, Hart, S P, Hill, M R, Hirani, N, Hubbard, R B, Mcanulty, R J, Millar, A B, Navaratnam, V, Oballa, E, Parfrey, H, Saini, G, Whyte, M K B, Zhang, Y, Kaminski, N, Adegunsoye, A, Strek, M E, Neighbors, M, Sheng, X R, Gudmundsson, G, Gudnason, V, Hatabu, H, Lederer, D J, Manichaikul, A, Newell Jr., J D, O'connor, G T, Ortega, V E, Xu, H, Fingerlin, T E, Bossé, Y, Hao, K, Joubert, P, Nickle, D C, Sin, D D, Timens, W, Furniss, D, Morris, A P, Zondervan, K, Hall, I P, Sayers, I, Tobin, M D, Maher, T M, Cho, M H, Hunninghake, G M, Schwartz, D A, Yaspan, B L, Molyneaux, P L, Flores, C, Noth, I, Jenkins, R G & Wain, L V 2020, ' Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis ', American Journal of Respiratory and Critical Care Medicine, vol. 201, no. 5, pp. 564-574 . https://doi.org/10.1164/rccm.201905-1017OC
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
American Journal of Respiratory and Critical Care Medicine, 201(5), 564-574. AMER THORACIC SOC
Allen, R J, Guillen-Guio, B, Oldham, J M, Ma, S-F, Dressen, A, Paynton, M L, Kraven, L M, Obeidat, M, Li, X, Ng, M, Braybrooke, R, Molina-Molina, M, Hobbs, B D, Putman, R K, Sakornsakolpat, P, Booth, H L, Fahy, W A, Hart, S P, Hill, M R, Hirani, N, Hubbard, R B, McAnulty, R J, Millar, A B, Navaratnam, V, Oballa, E, Parfrey, H, Saini, G, Whyte, M K B, Zhang, Y, Kaminski, N, Adegunsoye, A, Strek, M E, Neighbors, M, Sheng, X R, Gudmundsson, G, Gudnason, V, Hatabu, H, Lederer, D J, Manichaikul, A, Newell, J D, O'Connor, G T, Ortega, V E, Xu, H, Fingerlin, T E, Bossé, Y, Hao, K, Joubert, P, Nickle, D C, Sin, D D, Timens, W, Furniss, D, Morris, A P, Zondervan, K, Hall, I P, Sayers, I, Tobin, M D, Maher, T M, Cho, M H, Hunninghake, G M, Schwartz, D A, Yaspan, B L, Molyneaux, P L, Flores, C, Noth, I, Jenkins, R G & Wain, L V 2019, ' Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis ', American Journal of Respiratory and Critical Care Medicine . https://doi.org/10.1164/rccm.201905-1017OC
American Journal of Respiratory and Critical Care Medicine
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
American Journal of Respiratory and Critical Care Medicine, 201(5), 564-574. AMER THORACIC SOC
Allen, R J, Guillen-Guio, B, Oldham, J M, Ma, S-F, Dressen, A, Paynton, M L, Kraven, L M, Obeidat, M, Li, X, Ng, M, Braybrooke, R, Molina-Molina, M, Hobbs, B D, Putman, R K, Sakornsakolpat, P, Booth, H L, Fahy, W A, Hart, S P, Hill, M R, Hirani, N, Hubbard, R B, McAnulty, R J, Millar, A B, Navaratnam, V, Oballa, E, Parfrey, H, Saini, G, Whyte, M K B, Zhang, Y, Kaminski, N, Adegunsoye, A, Strek, M E, Neighbors, M, Sheng, X R, Gudmundsson, G, Gudnason, V, Hatabu, H, Lederer, D J, Manichaikul, A, Newell, J D, O'Connor, G T, Ortega, V E, Xu, H, Fingerlin, T E, Bossé, Y, Hao, K, Joubert, P, Nickle, D C, Sin, D D, Timens, W, Furniss, D, Morris, A P, Zondervan, K, Hall, I P, Sayers, I, Tobin, M D, Maher, T M, Cho, M H, Hunninghake, G M, Schwartz, D A, Yaspan, B L, Molyneaux, P L, Flores, C, Noth, I, Jenkins, R G & Wain, L V 2019, ' Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis ', American Journal of Respiratory and Critical Care Medicine . https://doi.org/10.1164/rccm.201905-1017OC
American Journal of Respiratory and Critical Care Medicine
Publisher's version (útgefin grein)
Rationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. Genome-wide ass
Rationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. Genome-wide ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f735d247fb5068243ea799597c642afa
https://www.research.manchester.ac.uk/portal/en/publications/genomewide-association-study-of-susceptibility-to-idiopathic-pulmonary-fibrosis(6fbf4813-b9fe-4644-bec4-7b50df3d4de2).html
https://www.research.manchester.ac.uk/portal/en/publications/genomewide-association-study-of-susceptibility-to-idiopathic-pulmonary-fibrosis(6fbf4813-b9fe-4644-bec4-7b50df3d4de2).html
Publikováno v:
ERJ Open Research
ERJ Open Research, Vol 3, Iss 1 (2017)
ERJ Open Research, Vol 3, Iss 1 (2017)
Idiopathic pulmonary fibrosis (IPF) has an unpredictable course and prognostic factors are incompletely understood. We aimed to identify prognostic factors, including multidimensional indices from a significant IPF cohort at the Bristol Interstitial
Autor:
George T. O'Connor, Gauri Saini, Helen Booth, Dominic Furniss, William A. Fahy, Ke Hao, Beatriz Guillen-Guio, Vilmundur Gudnason, Brian L. Yaspan, Imre Noth, Hanfei Xu, Hiroto Hatabu, Brian D. Hobbs, Ma'en Obeidat, Nik Hirani, Justin M. Oldham, Victor E. Ortega, David A. Schwartz, Simon P. Hart, Ani Manichaikul, Richard Hubbard, Xuan Li, Philippe Joubert, Michael Hill, Michael Ng, Ann B. Millar, Vidyia Navaratnam, Richard J. Allen, Rebecca Braybrooke, Ian Sayers, Ian P. Hall, Shwu-Fan Ma, Philip L. Molyneaux, Carlos Flores, Tasha E. Fingerlin, Martin D. Tobin, Gunnar Gudmundsson, Rachel K. Putman, Gary M. Hunninghake, Krina T. Zondervan, Moira K. B. Whyte, Robin J. McAnulty, Louise V. Wain, Andrew P. Morris, Michael H. Cho, David C. Nickle, Don D. Sin, Helen Parfrey, Toby M. Maher, Yohan Bossé, Maria Molina-Molina, John D. Newell, Eunice Oballa, Phuwanat Sakornsakolpat, David J. Lederer, R. Gisli Jenkins, Amy Dressen, Wim Timens, Luke M. Kraven, Megan L. Paynton
RationaleIdiopathic pulmonary fibrosis (IPF) is a complex lung disease characterised by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. The mechanisms by which this arises are poorly understood a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d678399307d65e16ef54c3cdc669cd0
https://doi.org/10.1101/636761
https://doi.org/10.1101/636761
Autor:
Paul F. Dellaripa, Joyce S. Lee, Sonye K. Danoff, Kirk D. Jones, Mary E. Strek, Elana J. Bernstein, Nik Hirani, David N O'Dwyer, Aryeh Fischer, Ganesh Raghu, David A. Lynch, Dinesh Khanna, Ann B. Millar, Seamas C. Donnelly, Vincent Cottin, Oliver Distler, Toby M. Maher, Virginia D. Steen, Richard M. Silver, Kevin K. Brown, Elizabeth R. Volkmann, Ronan H Mullan
Interstitial lung disease (ILD), a group of diffuse parenchymal lung disorders classified together based on specific clinical, radiologic, and histopathologic features, is often associated with significant morbidity and mortality and is a common mani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565f7957d469a1db7bd485c639603298
https://doi.org/10.5167/uzh-162843
https://doi.org/10.5167/uzh-162843
Publikováno v:
Kompass Pneumologie. 4:190-208
Das klinische Syndrom der akuten Lungenschädigung (ALI; acute lung injury) entwickelt sich basierend auf einer vorausgehenden akuten systemischen Entzündungsreaktion. Diese kann auf direktem oder indirektem Wege vielfältige Schäden an der Lunge h
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 5, p 1269 (2018)
Barratt, S L, Flower, V A, Pauling, J D & Millar, A B 2018, ' VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease ', International Journal of Molecular Sciences, vol. 19, no. 5, 1269 . https://doi.org/10.3390/ijms19051269
International Journal of Molecular Sciences
Barratt, S L, Flower, V A, Pauling, J D & Millar, A B 2018, ' VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease ', International Journal of Molecular Sciences, vol. 19, no. 5, 1269 . https://doi.org/10.3390/ijms19051269
International Journal of Molecular Sciences
Interstitial lung disease (ILD) encompasses a group of heterogeneous diseases characterised by varying degrees of aberrant inflammation and fibrosis of the lung parenchyma. This may occur in isolation, such as in idiopathic pulmonary fibrosis (IPF) o